英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Press Releases Archives - Page 27 of 31 - Novan
    Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders; Novan Focuses Strategic Direction and Announces Restructuring; Novan Reports First Quarter 2023 Financial Results and Provides Corporate Update; Novan to Report First Quarter 2023 Financial Results on May 15, 2023
  • Novan Announces Favorable Preclinical Safety Data and Intent to Advance . . .
    DURHAM, N C , Nov 09, 2021 — Novan, Inc (“the Company” or “Novan”) (Nasdaq: NOVN), today announced promising preclinical safety results with berdazimer sodium in a 14-day GLP repeat dose intranasal toxicity study
  • Novan Bolsters Commercialization Expertise with Election of Steven D . . .
    MORRISVILLE, N C , March 02, 2021 — Novan, Inc (“the Company” or “Novan”) (Nasdaq: NOVN), today announced the election of Steven D Skolsky to its Board of Directors Mr Skolsky is a well-established senior executive with over 35 years of experience in healthcare and the life sciences in both private and public sectors
  • First Patient Enrolled and Dosed in Novans SB206 Phase 3 Molluscum . . .
    MORRISVILLE, N C , June 04, 2019 — Novan, Inc (“the Company” or “Novan”) (Nasdaq:NOVN) today announced that the first patient has been dosed in the Company’s “B-SIMPLE” (Berdazimer Sodium In Molluscum Patients with Lesions) Phase 3 program The study is designed to evaluate topical nitric oxide product candidate SB206 for the
  • Novan Advances Organization and Strengthens Leadership Team
    MORRISVILLE, N C , April 12, 2018 — Novan, Inc (“the Company” or “Novan”) (NASDAQ:NOVN) today announced a number of key leadership and talent advancements that add to the existing foundation of the Company and enable its continued progress across key areas
  • Novan Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    The stock options were granted as an inducement material to the new employee entering into employment with Novan in accordance with Nasdaq Listing Rule 5635(c)(4)
  • Novan Conducts Guidance Meeting with FDA on SB204 Development Program
    MORRISVILLE, N C , Sept 25, 2017 — Novan, Inc (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that it has concluded a guidance meeting with the U S Food and Drug Administration (FDA) regarding SB204 for the treatment of acne vulgaris
  • Novan Announces Pricing of $5. 5 Million Public Offering
    MORRISVILLE, N C , Feb 27, 2020 — Novan, Inc (“the Company” or “Novan”) (NASDAQ:NOVN) today announced the pricing of the Company’s previously announced underwritten public offering of 18,333,334 shares of common stock (or pre-funded warrants to purchase common stock in lieu thereof) and warrants to purchase an aggregate of
  • Novan to Present at Piper Jaffray 28th Annual Healthcare Conference
    MORRISVILLE, N C , Nov 23, 2016 — Novan, Inc (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that Nathan Stasko, PhD, President and Chief Executive Officer of Novan, is scheduled to participate in a fireside chat at the Piper Jaffray 28 th Annual Healthcare Conference, Tuesday, Nov 29, 2016, 4:30 p m EST, in New York
  • Novan to Present at H. C. Wainwright 23rd Annual Global Investment . . .
    Novan, Inc is a late clinical-stage biotechnology company focused on leveraging its proprietary nitric oxide (NO) based technology platform, NITRICIL™ to generate macromolecular New Chemical Entities (NCEs) to treat multiple indications in dermatology, men’s and women’s health, infectious diseases, and various other medical conditions





中文字典-英文字典  2005-2009